PPTDF (PeptiDream) Moat Score: 5/10 (As of Jun. 27, 2026)


PPTDF PeptiDream Inc PPTDF
74 GF Score
Price $6.00
GF Value $10.04
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is PeptiDream Moat Score?

PeptiDream PPTDF 74 Moat Score is 5 as of Jun. 27, 2026. GuruFocus rates PPTDF with a GF Score™ of 74/100 and a GF Value™ of $10.04 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,404 Biotechnology companies, PeptiDream ranks better than 96.72% on this metric.

PeptiDream has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

PeptiDream has Narrow Moat: PeptiDream Inc has a solid narrow moat due to its proprietary peptide technology and valuable intellectual property. However, it faces competition in the biotech sector and lacks strong brand strength or customer loyalty.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes PeptiDream might have Narrow Moat - Solid narrow moat.

PeptiDream  (OTCPK:PPTDF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

PeptiDream Moat Score Related Terms

PPTDF vs VRTX, REGN, ALNY: Moat Score Comparison

For the Biotechnology subindustry, PeptiDream's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PeptiDream Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PeptiDream's Moat Score distribution charts can be found below:

* The bar in red indicates where PeptiDream's Moat Score falls into.


PPTDF
74GF Score
PeptiDream Inc PPTDF
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 5 mean?
PeptiDream (PPTDF) has a Moat Score of 5 as of Jun. 27, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, PeptiDream ranks #46 out of 1404 companies in the Biotechnology industry, placing it in the top 3.3%.
Is PeptiDream's Moat Score too high?
PeptiDream's current Moat Score is 5. The Biotechnology industry median Moat Score is 2.00. PeptiDream's value of 5 is 150% above this industry median. Based on the distribution chart, PeptiDream ranks #46 out of 1404 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, PeptiDream has a GF Score™ of 74/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PeptiDream's Moat Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, PeptiDream ranks #46 out of 1404 companies for Moat Score. This places PeptiDream in the top 3% of its industry — outperforming the majority of peers. The industry median Moat Score is 2.00. PeptiDream's value of 5 is 150% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,404 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PeptiDream's current Moat Score of 5 is 150% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PeptiDream's current Moat Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PeptiDream stock overvalued right now?
Based on GuruFocus' analysis, PeptiDream (PPTDF) is currently considered Possible Value Trap. The stock's GF Value™ is $10.04, compared to a current price of $6.00 — trading 40.2% below its estimated fair value. The current Moat Score is 5 and 150% above the Biotechnology industry median of 2.00. PeptiDream's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For PeptiDream (PPTDF), the current Moat Score is 5 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PeptiDream (PPTDF) Overvalued in 2026?

Based on GuruFocus' analysis, PeptiDream stock appears to be undervalued. The current stock price of $6.00 is trading 40.2% below its estimated GF Value™ of $10.04. GuruFocus considers PeptiDream to be Possible Value Trap.

Key valuation signals for PPTDF:

  • Moat Score: 5
  • GF Value™: $10.04 vs. price of $6.00 (40.2% below fair value)
  • GF Score™: 74/100 with 4 warning signs
  • Industry Position: 150% above the Biotechnology median (#46 of 1404)

No single metric tells the full story. See the PPTDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PeptiDream Business Description

Other Exchanges 4587:Japan
Address 3-25-23 Tonomachi, Kawasaki-ku, Kanagawa Prefecture, Kawasaki, JPN, 210-0821
PeptiDream Inc is engaged in the drug discovery and development business. The group utilizes PDPS, its proprietary drug discovery and development platform system, for drug discovery and development, and it conducts radiopharmaceutical business through a wholly owned subsidiary and is involved in the research, development, and manufacturing of pharmaceuticals, etc. Its reportable segments are Drug discovery and development business and Radiopharmaceutical business.
74GF Score

Get the complete analysis for PPTDF

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.00
Price
$10.04
GF Value